Changes in Beneficial Ownership · 4
Compugen Ltd.
CGENNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
zk2635673.xml
Filing details
- Report period
- 2026-07-09
- Issuer
- COMPUGEN LTD
- Issuer CIK
- 0001119774
- Trading symbol
- CGEN
- Rule 10b5-1 indication
- Checked
Reporting owner 1
- Name
- Levine Zurit
- Reporting owner CIK
- 0001972527
- Relationship
- Officer
- Officer title
- SVP, Business Development
- Address
- C/O COMPUGEN LTD., 26 HAROKMIM STREET, HOLON, ISRAEL, L3, 5885849
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | 2026-07-09 | M · Form 4[F1] | 1,875 | A | 0.8292 | 31,250 | D |
| Ordinary Shares | 2026-07-09 | S · Form 4[F1] | 1,875 | D | 2.50 | 29,375 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- S · Form 4
- Sale on the market or privately
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (right to buy) | 0.8292 | 2026-07-09 | M · Form 4[F1] | 1,875 | D | 0 | [F2] | 2032-11-09 | Ordinary Shares | 1,875 | 3,750 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Footnotes
- F1
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.↩ 1↩ 2↩ 3
- F2
- This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.↩ 1
Signature 1
- Signed
- /s/ Zurit Levine
- Date
- 2026-07-13